{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:33:57Z","timestamp":1765370037499,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.phrs.2022.106293","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T16:01:43Z","timestamp":1654790503000},"page":"106293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Clinical impact and disease evolution of SARS-CoV-2 infection in familial Mediterranean fever"],"prefix":"10.1016","volume":"182","author":[{"given":"Francesca","family":"Marinelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Caporilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annachiara","family":"Titolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2022.106293_bib1","article-title":"Therapeutic strategies against COVID-19","volume":"91","author":"Esposito","year":"2020","journal-title":"Acta Biomed."},{"issue":"8","key":"10.1016\/j.phrs.2022.106293_bib2","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis and treatment of Coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2022.106293_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discov."},{"issue":"2","key":"10.1016\/j.phrs.2022.106293_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.phrs.2022.106293_bib5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41422-020-0391-9","article-title":"Dysregulated adaptive immune response contributes to severe COVID-19","volume":"30","author":"Yu","year":"2020","journal-title":"Cell Res."},{"issue":"11","key":"10.1016\/j.phrs.2022.106293_bib6","article-title":"Familial Mediterranean fever and COVID-19: friends or foes?","volume":"11","author":"Stella","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106293_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0049-0172(96)80012-6","article-title":"The changing face of familial Mediterranean fever","volume":"26","author":"Livneh","year":"1996","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.phrs.2022.106293_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/jcm10040605","article-title":"COVID-19 in autoinflammatory diseases with immunosuppressive treatment","volume":"10","author":"Welzel","year":"2021","journal-title":"J. Clin. Med."},{"issue":"23","key":"10.1016\/j.phrs.2022.106293_bib9","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.phrs.2022.106293_bib10","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1111\/jcmm.15607","article-title":"Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19\/SARS-CoV-2","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.phrs.2022.106293_bib11","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.phrs.2022.106293_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(20)30304-0","article-title":"COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?","volume":"8","author":"Fan","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"10239","key":"10.1016\/j.phrs.2022.106293_bib13","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","article-title":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","volume":"395","author":"Cummings","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.phrs.2022.106293_bib14","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/apa.15271","article-title":"Why is COVID-19 so mild in children?","volume":"109","author":"Brodin","year":"2020","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.phrs.2022.106293_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108420","article-title":"COVID-19 - Considerations for the paediatric rheumatologist","volume":"214","author":"Hedrich","year":"2020","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106293_bib16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S2352-4642(20)30135-8","article-title":"The immune system of children: the key to understanding SARS-CoV-2 susceptibility?","volume":"4","author":"Carsetti","year":"2020","journal-title":"Lancet Child Adolesc. Health"},{"issue":"1","key":"10.1016\/j.phrs.2022.106293_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ajpath.2020.08.009","article-title":"Immunopathology of hyperinflammation in COVID-19","volume":"191","author":"Gustine","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106293_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/joim.13144","article-title":"Cytokine storm syndrome in coronavirus disease 2019: a narrative review","volume":"289","author":"Gao","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.phrs.2022.106293_bib19","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106293_bib20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.phrs.2022.106293_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108049","article-title":"Coronavirus disease-2019: a review on the disease exacerbation via cytokine storm and concurrent management","volume":"99","author":"Sunkara","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106293_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018cytokine storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"issue":"10223","key":"10.1016\/j.phrs.2022.106293_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.phrs.2022.106293_bib24","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","article-title":"Cardiovascular complications in COVID-19","volume":"38","author":"Long","year":"2020","journal-title":"Am. J. Emerg. Med."},{"issue":"5","key":"10.1016\/j.phrs.2022.106293_bib25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/BOR.0000000000000821","article-title":"Update in familial Mediterranean fever","volume":"33","author":"Ozen","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106293_bib26","article-title":"Familial Mediterranean fever: assessing the overall clinical impact and formulating treatment plans","volume":"11","author":"Manna","year":"2019","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"6","key":"10.1016\/j.phrs.2022.106293_bib27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/1744666X.2017.1280396","article-title":"A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner","volume":"13","author":"Rigante","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2022.106293_bib28","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11739-021-02751-7","article-title":"The everchanging framework of autoinflammation","volume":"16","author":"Manna","year":"2021","journal-title":"Intern. Emerg. Med."},{"issue":"9","key":"10.1016\/j.phrs.2022.106293_bib29","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10067-014-2722-z","article-title":"Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome","volume":"33","author":"Rigante","year":"2014","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106293_bib30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/039463201402700404","article-title":"Current advances in the understanding and treatment of mevalonate kinase deficiency","volume":"27","author":"Esposito","year":"2014","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106293_bib31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.phrs.2022.106293_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5152\/eurjrheum.2018.18023","article-title":"Novel presentations of periodic fever syndromes: discrepancies between genetic and clinical diagnoses","volume":"6","author":"Hoang","year":"2019","journal-title":"Eur. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106293_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jebm.12406","article-title":"Phenotype variability of autoinflammatory disorders in the pediatric patient: a pictorial overview","volume":"13","author":"Rigante","year":"2020","journal-title":"J. Evid. Based Med."},{"issue":"8","key":"10.1016\/j.phrs.2022.106293_bib34","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106293_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jebm.12377","article-title":"When, how, and why do fevers hold children hostage?","volume":"13","author":"Rigante","year":"2020","journal-title":"J. Evid. Based Med."},{"issue":"1","key":"10.1016\/j.phrs.2022.106293_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00296-019-04443-0","article-title":"Familial Mediterranean fever: assessment of clinical manifestations, pregnancy, genetic mutational analyses, and disease severity in a national cohort","volume":"40","author":"Bodur","year":"2020","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.phrs.2022.106293_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.autrev.2014.10.005","article-title":"Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis","volume":"14","author":"Cantarini","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.phrs.2022.106293_bib38","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/medicina57101049","article-title":"Amyloidosis and glomerular diseases in familial Mediterranean fever","volume":"57","author":"Siligato","year":"2021","journal-title":"Medicina"},{"issue":"Sl-2","key":"10.1016\/j.phrs.2022.106293_bib39","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3906\/sag-2008-11","article-title":"Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review","volume":"50","author":"Tufan","year":"2020","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.phrs.2022.106293_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.imlet.2017.11.013","article-title":"New mosaic tiles in childhood hereditary autoinflammatory disorders","volume":"193","author":"Rigante","year":"2018","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2022.106293_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/clpt.2013.148","article-title":"Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics","volume":"95","author":"Grattagliano","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2022.106293_bib42","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/annrheumdis-2016-210092","article-title":"Development of the autoinflammatory disease damage index (ADDI)","volume":"76","author":"Ter Haar","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2022.106293_bib43","article-title":"Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area","volume":"2","author":"Bourguiba","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.phrs.2022.106293_bib44","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00296-021-04892-6","article-title":"The impact of COVID-19 on familial Mediterranean fever: a nationwide study","volume":"41","author":"G\u00fcnendi","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"9","key":"10.1016\/j.phrs.2022.106293_bib45","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00296-020-04645-x","article-title":"Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic","volume":"40","author":"Haslak","year":"2020","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.phrs.2022.106293_bib46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00296-021-04812-8","article-title":"COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study","volume":"41","author":"G\u00fcven","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"SI","key":"10.1016\/j.phrs.2022.106293_bib47","doi-asserted-by":"crossref","first-page":"SI85","DOI":"10.1093\/rheumatology\/keab577","article-title":"Incidence and course of COVID-19 hospitalizations among patients with familial Mediterranean fever","volume":"60","author":"Kharouf","year":"2021","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.phrs.2022.106293_bib48","first-page":"924","article-title":"Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3 randomised double-blinded adaptive placebo-controlled multicentre trial. Lancet","volume":"9","author":"Tardif","year":"2021","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.phrs.2022.106293_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13136","article-title":"Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with Coronavirus disease 2019: the GRECCO-19 randomized clinical trial","volume":"3","author":"Deftereos","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.phrs.2022.106293_bib50","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00296-021-04809-3","article-title":"COVID-19 in patients with familial Mediterranean fever treated with colchicine: case-based review","volume":"41","author":"Nas","year":"2021","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.phrs.2022.106293_bib51","article-title":"COVID-19 infection in a patient with FMF: does colchicine have a protective effect","volume":"Jun 5","author":"Kobak","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.phrs.2022.106293_bib52","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13645","article-title":"Colchicine use might be associated with lower mortality in COVID-19 patients: a meta-analysis","volume":"51","author":"Elshafei","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.phrs.2022.106293_bib53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/vaccines9020127","article-title":"Why it is important to develop an effective and safe pediatric COVID-19 vaccine","volume":"9","author":"Principi","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.phrs.2022.106293_bib54","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41435-020-0103-y","article-title":"COVID-19 meets cystic fibrosis: for better or worse?","volume":"21","author":"Peckham","year":"2020","journal-title":"Genes Immun."},{"key":"10.1016\/j.phrs.2022.106293_bib55","article-title":"COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologics","volume":"5","author":"Peet","year":"2021","journal-title":"Rheumatol. Adv. Pract."},{"key":"10.1016\/j.phrs.2022.106293_bib56","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/annrheumdis-2021-220272","article-title":"Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort","volume":"80","author":"Geisen","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.phrs.2022.106293_bib57","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00296-020-04612-6","article-title":"Implications of COVID-19 in pediatric rheumatology","volume":"40","author":"Batu","year":"2020","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.phrs.2022.106293_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109889","article-title":"Could MEFV mutation carriage status have a protective role for COVID-19 pandemic?","volume":"144","author":"Kavuk\u00e7u","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.phrs.2022.106293_bib59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/85893","article-title":"Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states","volume":"27","author":"Schaner","year":"2001","journal-title":"Nat. Genet."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:38:14Z","timestamp":1760913494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822002389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":59,"alternative-id":["S1043661822002389"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106293","relation":{},"ISSN":["1043-6618"],"issn-type":[{"type":"print","value":"1043-6618"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical impact and disease evolution of SARS-CoV-2 infection in familial Mediterranean fever","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106293"}}